Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 329

1.

Acitretin: Monotherapy or Combined Therapy for Hidradenitis Suppurativa?

Tan MG, Shear NH, Walsh S, Alhusayen R.

J Cutan Med Surg. 2016 Jul 18. pii: 1203475416659858. [Epub ahead of print]

PMID:
27432818
2.

Major psychological complications and decreased health-related quality of life among survivors of Stevens-Johnson syndrome and toxic epidermal necrolysis.

Dodiuk-Gad RP, Olteanu C, Feinstein A, Hashimoto R, Alhusayen R, Whyte-Croasdaile S, Finkelstein Y, Burnett M, Sade S, Cartotto R, Jeschke M, Shear NH.

Br J Dermatol. 2016 Jun 13. doi: 10.1111/bjd.14799. [Epub ahead of print] No abstract available.

PMID:
27292197
3.

Management of Pain Associated with Selected Conditions in Dermatology.

Al-Ghazawi FM, Ramien ML, Brassard A, Shear NH, Beecker J.

Am J Clin Dermatol. 2016 Jun 2. [Epub ahead of print]

PMID:
27256497
4.

The Role of IL-17 in the Pathogenesis of Psoriasis and Update on IL-17 Inhibitors for the Treatment of Plaque Psoriasis.

AbuHilal M, Walsh S, Shear N.

J Cutan Med Surg. 2016 May 20. pii: 1203475416651605. [Epub ahead of print] Review.

PMID:
27207350
5.

Health-related quality-of-life improvements during 98 weeks of infliximab therapy in patients with plaque-type psoriasis in real-world practice.

Shear NH, Hartmann M, Toledo-Bahena ME, Gilbert M, Katsambas A, Yao R, Popmihajlov Z.

Qual Life Res. 2016 Aug;25(8):2031-40. doi: 10.1007/s11136-015-1224-z. Epub 2016 Feb 11.

PMID:
26869477
6.

Comparative effectiveness of biologic agents for the treatment of psoriasis in a real-world setting: Results from a large, prospective, observational study (Psoriasis Longitudinal Assessment and Registry [PSOLAR]).

Strober BE, Bissonnette R, Fiorentino D, Kimball AB, Naldi L, Shear NH, Goyal K, Fakharzadeh S, Calabro S, Langholff W, You Y, Galindo C, Lee S, Lebwohl MG.

J Am Acad Dermatol. 2016 May;74(5):851-861.e4. doi: 10.1016/j.jaad.2015.12.017. Epub 2016 Feb 4.

7.

Use of Apremilast in Combination With Other Therapies for Treatment of Chronic Plaque Psoriasis: A Retrospective Study.

AbuHilal M, Walsh S, Shear N.

J Cutan Med Surg. 2016 Jul;20(4):313-6. doi: 10.1177/1203475416631328. Epub 2016 Feb 4.

PMID:
26848145
8.

The 9th International Congress on Cutaneous Adverse Drug Reactions at the 23rd World Congress of Dermatology in Vancouver, 2015.

Dodiuk-Gad RP, Olteanu C, Chung WH, Shear NH.

Drug Saf. 2016 Mar;39(3):271-6. doi: 10.1007/s40264-015-0390-9. No abstract available.

PMID:
26798049
9.

Management of acne: Canadian clinical practice guideline.

Asai Y, Baibergenova A, Dutil M, Humphrey S, Hull P, Lynde C, Poulin Y, Shear NH, Tan J, Toole J, Zip C.

CMAJ. 2016 Feb 2;188(2):118-26. doi: 10.1503/cmaj.140665. Epub 2015 Nov 16. No abstract available.

PMID:
26573753
10.

Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: An Update.

Dodiuk-Gad RP, Chung WH, Valeyrie-Allanore L, Shear NH.

Am J Clin Dermatol. 2015 Dec;16(6):475-93. doi: 10.1007/s40257-015-0158-0.

PMID:
26481651
11.

Treatment of toxic epidermal necrolysis in North America.

Dodiuk-Gad RP, Olteanu C, Jeschke MG, Cartotto R, Fish J, Shear NH.

J Am Acad Dermatol. 2015 Nov;73(5):876-7.e2. doi: 10.1016/j.jaad.2015.08.008. No abstract available.

PMID:
26475545
12.

Scientific evidence for the use of current traditional systemic therapies in patients with hidradenitis suppurativa.

Alhusayen R, Shear NH.

J Am Acad Dermatol. 2015 Nov;73(5 Suppl 1):S42-6. doi: 10.1016/j.jaad.2015.07.049. Review.

PMID:
26470615
13.

Impact of Cosmetic Camouflage on the Quality of Life of Children With Skin Disease and Their Families.

Salsberg JM, Weinstein M, Shear N, Lee M, Pope E.

J Cutan Med Surg. 2016 May;20(3):211-5. doi: 10.1177/1203475415595175. Epub 2015 Jul 10.

PMID:
26162859
14.

Granulomatous Drug Eruptions.

Dodiuk-Gad RP, Shear NH.

Dermatol Clin. 2015 Jul;33(3):525-39. doi: 10.1016/j.det.2015.03.015. Review.

PMID:
26143430
15.

Loss of Work Productivity and Quality of Life in Patients With Autoimmune Bullous Dermatoses.

Heelan K, Hitzig SL, Knowles S, Drucker AM, Mittmann N, Walsh S, Shear NH.

J Cutan Med Surg. 2015 Nov-Dec;19(6):546-54. doi: 10.1177/1203475415582317. Epub 2015 Apr 17.

PMID:
25888597
16.

Pemphigus and associated comorbidities: a cross-sectional study.

Heelan K, Mahar AL, Walsh S, Shear NH.

Clin Exp Dermatol. 2015 Aug;40(6):593-9. doi: 10.1111/ced.12634. Epub 2015 Mar 18.

PMID:
25786337
17.

Cost and Resource Use of Pemphigus and Pemphigoid Disorders Pre- and Post-Rituximab.

Heelan K, Hassan S, Bannon G, Knowles S, Walsh S, Shear NH, Mittmann N.

J Cutan Med Surg. 2015 May-Jun;19(3):274-82. doi: 10.2310/7750.2014.14092. Epub 2015 Mar 13.

PMID:
25775641
18.

Insights and advances in chronic urticaria: a Canadian perspective.

Sussman G, Hébert J, Gulliver W, Lynde C, Waserman S, Kanani A, Ben-Shoshan M, Horemans S, Barron C, Betschel S, Yang WH, Dutz J, Shear N, Lacuesta G, Vadas P, Kobayashi K, Lima H, Simons FE.

Allergy Asthma Clin Immunol. 2015 Feb 11;11(1):7. doi: 10.1186/s13223-015-0072-2. eCollection 2015.

19.

Systemic glucocorticoids: important issues and practical guidelines for the dermatologist.

Dodiuk-Gad RP, Ish-Shalom S, Shear NH.

Int J Dermatol. 2015 Jun;54(6):723-9. doi: 10.1111/ijd.12642. Epub 2015 Feb 13. Review.

PMID:
25683616
20.

Pemphigus herpetiformis: a case series and review of the literature.

Laws PM, Heelan K, Al-Mohammedi F, Walsh S, Shear NH.

Int J Dermatol. 2015 Sep;54(9):1014-22. doi: 10.1111/ijd.12582. Epub 2015 Jan 20. Review.

PMID:
25600350
Items per page

Supplemental Content

Write to the Help Desk